Ayala Pharmaceuticals Buy Hold or Sell Recommendation

ADXSDelisted Stock  USD 1.38  0.34  32.69%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Ayala Pharmaceuticals is 'Not Rated'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Ayala Pharmaceuticals given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Ayala Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest.
Note, we conduct extensive research on individual companies such as Ayala and provide practical buy, sell, or hold advice based on investors' constraints. Ayala Pharmaceuticals. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest.

Execute Ayala Pharmaceuticals Buy or Sell Advice

The Ayala recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ayala Pharmaceuticals. Macroaxis does not own or have any residual interests in Ayala Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ayala Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Ayala PharmaceuticalsBuy Ayala Pharmaceuticals
Not Rated
For the selected time horizon Ayala Pharmaceuticals has a Risk Adjusted Performance of 0.0844, Jensen Alpha of 1.79, Total Risk Alpha of 1.26, Sortino Ratio of 0.1153 and Treynor Ratio of 3.14
We provide trade advice to complement the prevailing expert consensus on Ayala Pharmaceuticals. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Ayala Pharmaceuticals is not overpriced, please confirm all Ayala Pharmaceuticals fundamentals, including its book value per share, market capitalization, as well as the relationship between the ebitda and number of shares shorted . Given that Ayala Pharmaceuticals is a hitting penny stock territory we recommend to closely look at its price to earning.

Ayala Pharmaceuticals Trading Alerts and Improvement Suggestions

Ayala Pharmaceuticals is not yet fully synchronised with the market data
Ayala Pharmaceuticals may become a speculative penny stock
Ayala Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 250 K. Net Loss for the year was (16.24 M) with profit before overhead, payroll, taxes, and interest of 3.24 M.
Ayala Pharmaceuticals currently holds about 28.15 M in cash with (16.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Ayala Pharmaceuticals current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ayala analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ayala analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Recommendation Mean2.00
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Ayala Pharmaceuticals Returns Distribution Density

The distribution of Ayala Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Ayala Pharmaceuticals' future price movements. The chart of the probability distribution of Ayala Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Ayala Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ayala Pharmaceuticals returns is essential to provide solid investment advice for Ayala Pharmaceuticals.
Mean Return
1.81
Value At Risk
-15.09
Potential Upside
30.59
Standard Deviation
19.28
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ayala Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Ayala Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ayala . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Ayala Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Ayala Pharmaceuticals? Buying financial instruments such as Ayala OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Ayala Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Wholesale Thematic Idea Now

Wholesale
Wholesale Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Wholesale theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wholesale Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in Ayala OTC Stock

If you are still planning to invest in Ayala Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ayala Pharmaceuticals' history and understand the potential risks before investing.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years